AVITA Medical Target Price

Analysts' average 12-month price target for AVITA Medical is $10.

Get informed when a big investor buys or sells

+ Follow

Share Price

$16.32

Average Target Price

$10.00

38.7% downside

3 analysts in the last 4 months

High: $12 | Low: $7

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-28	Lake Street	$12	26.5% downside
2026-08-19	BTIGRyan Zimmerman	$11	32.6% downside
2026-08-07	BTIGRyan Zimmerman	$7	57.1% downside
2026-05-15	Lake Street	$6	63.2% downside
2026-03-26	Northland Securities	$10	38.7% downside
2026-01-16	Lake Street	$3.5	78.6% downside
2025-10-17	Lake StreetFrank Takkinen	$4	75.5% downside
2025-01-08	Lake StreetBrooks O'Neil	$14	14.2% downside
2024-05-14	Piper SandlerMatt O'Brien	$9	44.9% downside

AVITA Medical (RCEL) FAQ

AVITA Medical (RCEL) currently reports a target price of $10. Use the charts on this page to explore AVITA Medical's target price history and peer comparisons.

Analysts' average 12-month price target for AVITA Medical is $10, about 38.7% downside from the current share price of $16.32. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $10, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AVITA Medical, and consider following RCEL for alerts when major investors trade the stock.